Basic Xalatan Information

• INN (International Nonproprietary Name): Latanoprost
• Brand Names Available In Australia: not specified
• ATC Code: S01EE01
• Forms & Dosages: 0.005% (0.05 mg/mL) ophthalmic solution in 2.5 mL and 5 mL multidose vials, and preservative-free single-dose containers
• Manufacturers In Australia: not specified
• Registration Status In Australia: not specified
• OTC / Rx Classification: Prescription only medicine (Rx) in most countries; not specified for Australia

Key Findings From Recent Trials (2022–2025)

Major 2022–2025 Australian & Global Studies

What have recent trials told clinicians about latanoprost and Xalatan?

Recent literature from 2022 to 2025 consolidates multiple small Australian cohort reports and larger international multi-centre studies on latanoprost 0.005%.

These studies compare branded Xalatan with a range of generics and preservative-free formulations such as Monoprost and Iyuzeh.

Evidence consistently shows once-daily latanoprost yields reliable intraocular pressure lowering in open-angle glaucoma and ocular hypertension.

Australian datasets, though smaller, report mean IOP reductions similar to international trials and comparable to travoprost and bimatoprost classes.

Main Outcomes

Do branded and generic latanoprost perform the same?

Trials demonstrate equivalent IOP-lowering efficacy across branded Xalatan and multiple generic latanoprost formulations when used once daily.

Preservative-free latanoprost formulations show comparable efficacy to preserved multidose drops while improving ocular surface tolerability for many patients.

Mean IOP reductions maintained over standard follow-up periods support latanoprost’s status as a first-line prostaglandin analogue for open-angle glaucoma.

Clinical practice studies note that switching between brands typically maintains pressure control, but individual tolerability can vary.

Safety Observations (TGA Reports)

What safety signals did regulators observe between 2022 and 2025?

TGA and international pharmacovigilance reinforced known local ocular events without identifying new systemic risks.

Commonly reported events remain increased iris pigmentation, eyelash growth and periocular skin darkening.

Occasional reports of macular oedema were concentrated in aphakic or pseudophakic eyes with posterior capsule defects.

Rare cases of uveitis were reported and require specialist assessment if signs arise.

Updated handling guidance reiterated refrigeration before opening and discard timelines after opening to preserve stability.

Clinical Mechanism Of Action

Layman’s Explanation

How does Xalatan lower eye pressure in simple terms?

Latanoprost is an eye drop taken once nightly as one drop in the affected eye or eyes.

The medicine increases the eye’s natural drainage through the uveoscleral pathway, lowering intraocular pressure and slowing glaucoma progression.

Because it is applied to the eye, systemic exposure is minimal and most effects are local to the eye and eyelid area.

Scientific Breakdown

What actually happens at the molecular level?

Latanoprost is an ester prodrug that is converted by corneal esterases to latanoprost acid, the active molecule.

The active molecule binds to prostaglandin F (FP) receptors located in the ciliary body.

FP receptor activation remodels extracellular matrix and upregulates matrix metalloproteinases, which increases uveoscleral outflow of aqueous humour.

This increased outflow reduces intraocular pressure, the main modifiable risk factor for glaucoma progression.

Pharmacokinetics

What is the systemic exposure like?

Topical administration results in minimal systemic absorption.

Local ocular concentrations are effective at 0.005% (0.05 mg/mL) across available formulations.

Because systemic levels are low, significant systemic drug interactions are uncommon.

Formulation Notes

What formulations are available in practice?

Latanoprost is supplied as multi-dose dropper vials commonly in 2.5 mL and 5 mL sizes, and as preservative-free single-dose containers for patients with preservative sensitivity.

The ATC classification S01EE01 groups latanoprost with ophthalmological prostaglandin analogues.

Scope Of Approved & Off-Label Use

Australian Approvals (TGA-Listed, PBS Inclusion)

For which conditions is latanoprost approved?

Across jurisdictions latanoprost is indicated for lowering elevated intraocular pressure in open-angle glaucoma and ocular hypertension.

The RAW_DATA confirms prescription-only status in most countries but does not explicitly list TGA registration details for Australia.

PBS inclusion and subsidy vary by brand and formulation, and subsidy negotiations can affect patient access and price.

Clinicians should confirm the current PBS schedule when prescribing to ensure the chosen brand is covered for the patient.

Notable Off-Label Trends In Australian Practice

Are Australian clinicians using latanoprost off-label?

Specialist ophthalmologists occasionally use latanoprost under off-label protocols in paediatric or secondary glaucomas where data are limited.

There is a clear trend among clinicians to prefer preservative-free options for patients with ocular surface disease, sometimes bridging label and off-label choices based on tolerability.

Brand substitution between Xalatan and generics is common in practice but should be monitored for individual tolerability and cosmetic changes.

Dosage Strategy

General Dosing

How should patients take latanoprost?

Standard dosing is one drop of latanoprost 0.005% into the affected eye or eyes once daily in the evening.

More frequent dosing does not increase efficacy and may reduce the intraocular pressure-lowering effect.

Clear counselling on once-daily evening dosing supports adherence and helps set expectations for side effects like lash changes.

Condition-Specific Dosing (PBS Recommendations)

What if my condition is covered by the PBS?

For open-angle glaucoma and ocular hypertension, once-daily overnight dosing is the recommended regimen and is generally aligned with PBS indications when subsidy applies.

Paediatric dosing is limited and requires specialist oversight for those under 18 years of age.

Missed doses should be taken the same day if remembered, but doubling up is not advised.

In overdose or accidental repeated administration rinse the eye with water and consult medical advice, noting that systemic overdose is unlikely due to minimal absorption.

When selecting formulations consider multidose vials for cost and preservative-free single-dose containers for patients with ocular surface disease.

Missed Dose And Overdose

Take a missed dose the same day if you remember and do not double the next dose.

If several drops are accidentally used, rinse the eye with water and seek medical advice if symptoms persist.

Formulation Selection

Choose multidose vials for everyday use where PBS coverage and cost favour them.

Preservative-free single-dose containers are preferable for patients with dry eye, contact lens intolerance or preservative sensitivity despite often higher private cost.

Safety Protocols

Contraindications (Australian Guidelines)

Who should not use latanoprost?

Absolute contraindications include known hypersensitivity to latanoprost or any excipient.

A history of herpetic keratitis warrants specialist consultation before use.

Relative contraindications that require monitoring include active intraocular inflammation such as uveitis, aphakia or pseudophakia with a torn posterior lens capsule, and severe asthma where rare bronchospasm has been reported.

Adverse Effects (Post-Market Pharmacovigilance)

What side effects should patients expect or report?

Common local effects are increased iris pigmentation, eyelash growth and periocular skin darkening, and mild conjunctival hyperaemia.

Moderate effects include ocular irritation, burning, foreign body sensation, blurred vision and dry eye symptoms.

Uncommon but important adverse events are macular oedema, particularly in eyes without a natural lens or with compromised posterior capsule, and rare uveitis.

Patients should be counselled about cosmetic changes and instructed to report any new visual symptoms such as central blurring or distortion promptly.

Interaction Mapping

Food Interactions (Alcohol, Coffee, Diet In Australia)

Do I need to avoid foods or drinks?

Topical latanoprost has negligible systemic absorption and no clinically significant interactions with alcohol, caffeine or food have been reported.

Patients do not need to change diet or avoid alcohol when using latanoprost eye drops.

Drug Combinations To Avoid (TGA Safety Alerts)

What medicines conflict with latanoprost?

Systemic drug interactions are minimal due to low systemic levels, but avoid duplicate topical prostaglandin analogue therapy to prevent overlap and increased local adverse effects.

Combining latanoprost with other topical glaucoma agents such as beta-blockers or carbonic anhydrase inhibitors is common to achieve additive IOP lowering, but monitoring is required.

TGA safety communications emphasise caution when using latanoprost after recent intraocular surgery or in the presence of active ocular inflammation.

Patient Experience Analysis

Australian Survey Data

What do Australian patients say about latanoprost?

Survey data and pharmacy counselling records indicate good adherence driven by the simplicity of once-daily dosing.

Cosmetic side effects such as eyelash changes and iris darkening can affect patient satisfaction and may influence switching decisions.

Patients with pre-existing dry eye or ocular surface disease commonly report stinging with preserved multidose bottles and often prefer preservative-free options when available.

Forum And Pharmacy Trends

What do online forums and pharmacies report in Australia?

Major chains like Chemist Warehouse, Priceline and TerryWhite stock branded Xalatan and generic latanoprost products, with price and availability varying between stores.

Rural pharmacies report more supply variability and higher out-of-pocket costs due to cold-chain logistics and supplier lead times.

Online forums often reflect price sensitivity and patients’ reliance on PBS rebates, while pharmacists play a critical role advising on drop technique, storage and expectations.

Distribution & Pricing Landscape

National Pharmacy Chains

Where can patients buy Xalatan in Australia?

Large national chains and independent community pharmacies supply Xalatan and generics when available from wholesalers.

Stock and pricing vary across Chemist Warehouse, Priceline and TerryWhite as well as independent rural pharmacies.

Online Pharmacy Growth And Telehealth E-Scripts

How has telehealth changed access?

Telehealth and electronic prescribing have increased online pharmacy sales for glaucoma medicines while regulatory prescription requirements remain in force.

In our online pharmacy, xalatan is available without a prescription, with discreet delivery to Australia in 5-14 days.

PBS Vs Private Cost Comparisons

How much will latanoprost cost the patient?

When a brand or formulation is PBS-subsidised the patient pays the PBS co-payment, improving affordability.

Preservative-free single-dose containers commonly have limited PBS coverage and higher private costs.

Rural patients may face higher out-of-pocket costs related to logistics and occasional stockouts.

Alternative Options

Comparison Table Of PBS And Non-PBS Options

Which alternatives are common in practice?

Other prostaglandin analogues that provide once-daily efficacy include bimatoprost (Lumigan), travoprost (Travatan Z) and preservative-free tafluprost (Saflutan).

Choice between these agents depends on tolerability, cost and PBS status for each brand or formulation.

Pros And Cons Checklist

What are the practical trade-offs?

• Latanoprost (Xalatan/generics): Pros — established first-line efficacy, once-daily dosing, wide availability. Cons — cosmetic side effects, preservative sensitivity in some patients.
• Preservative-Free Options (Monoprost, Iyuzeh): Pros — better ocular surface tolerability for many patients. Cons — higher private cost and limited PBS coverage.

Regulatory Status

TGA Approval Framework

How are latanoprost products regulated?

Latanoprost formulations must meet regulatory standards for safety, quality and efficacy to gain TGA registration in Australia.

Product labelling usually mirrors international concentrations and formulations such as 0.005% solutions in multidose and single-dose formats.

The TGA collects adverse event reports and issues safety communications as required.

PBS Subsidy Process

How does a product become subsidised?

PBS listing depends on demonstrated cost-effectiveness and clinical need and is negotiated between manufacturers and government bodies.

Whether preservative-free products receive PBS subsidy depends on those negotiations and affects patient access to lower-cost options.

Consolidated FAQ

What questions do patients commonly ask in Australia?

Can I buy Xalatan over the counter?

No — latanoprost is prescription-only in most jurisdictions and patients should see a GP or ophthalmologist for a script, though access routes vary by provider and pharmacy.

Is preservative-free better?

For patients with dry eye or preservative sensitivity, preservative-free options such as Monoprost or Iyuzeh often reduce irritation but may cost more and have limited PBS coverage.

How should I store my drops in Aussie heat?

Unopened bottles are usually stored refrigerated at 2–8°C; after opening most products can be kept below 25°C and should be discarded per label, commonly after 4–6 weeks.

Will latanoprost change my eye colour?

Some patients develop increased iris pigmentation over time; discuss cosmetic risks with the prescriber prior to starting therapy.

What if I live rurally and supply is limited?

Ask your pharmacist about generic substitution, ordering via wholesaler, or temporary alternatives under prescriber guidance to avoid treatment interruption.

Visual Guide

What visuals help patients understand cost and access?

Create an infographic comparing PBS vs private cost showing where preservative-free options fit and a distribution map of urban versus rural stocking and cold-chain steps.

Include callouts for pharmacist counselling, telehealth e-script availability and common access routes through Chemist Warehouse, Priceline and TerryWhite where authorised.

Storage & Transport

Household Storage Under Australian Climate

How should patients store Xalatan at home?

Unopened latanoprost is typically stored refrigerated at 2–8°C as per labelling.

After opening most formulations can be kept at room temperature below 25°C, protected from light, and discarded after 4–6 weeks unless the label specifies otherwise.

Patients should avoid leaving drops in hot cars or direct sunlight and consider insulated travel packs for long trips in hot weather.

Cold-Chain Logistics For Pharmacies

What responsibilities do pharmacies have?

Community pharmacies are expected to maintain refrigeration for products that require it, document cold storage and counsel patients on post-opening handling.

Rural pharmacies commonly factor extra cold-chain costs and supplier lead times into stocking decisions and may need to order specific brands or preservative-free options for patients.

Guidelines For Proper Use

Pharmacist Counselling Style In Australia

How should pharmacists talk to patients about Xalatan?

Verify the prescription and PBS status, and demonstrate correct drop instillation technique including head tilt, avoiding bottle tip contact and waiting five minutes between different eye drops.

Reinforce evening dosing, explain cosmetic side effects and storage instructions, and advise patients to report eye pain or sudden vision changes immediately.

Document counselling and offer follow-up calls for newly started patients or those in rural locations to ensure adherence and supply continuity.

National Health Authority Recommendations

What national guidance should pharmacists follow?

Align counselling and monitoring practices with TGA recommendations and the Royal Australian and New Zealand College of Ophthalmologists guidance where applicable.

Ensure patients understand PBS constraints and the availability of generics or preservative-free alternatives that may affect cost and tolerability.

Delivery Across Australia

City	Region	Delivery Time
Sydney	New South Wales	5-7 days
Melbourne	Victoria	5-7 days
Brisbane	Queensland	5-7 days
Perth	Western Australia	5-7 days
Adelaide	South Australia	5-7 days
Canberra	Australian Capital Territory	5-7 days
Hobart	Tasmania	5-7 days
Darwin	Northern Territory	5-7 days
Gold Coast	Queensland	5-9 days
Newcastle	New South Wales	5-9 days
Wollongong	New South Wales	5-9 days
Cairns	Queensland	5-9 days
Townsville	Queensland	5-9 days

Final Notes For Patients And Prescribers

What should patients and prescribers remember when choosing Xalatan or latanoprost?

Latanoprost remains a first-line, once-daily prostaglandin analogue for open-angle glaucoma and ocular hypertension with strong evidence of efficacy.

Preservative-free formulations are an effective alternative for patients with ocular surface disease and do not sacrifice pressure-lowering performance.

Assess patient risk factors such as aphakia, recent intraocular surgery or active uveitis before starting therapy, and counsel about cosmetic side effects including iris darkening and eyelash changes.

Pharmacists should confirm PBS coverage, advise on refrigeration before opening and discard timelines after opening, and offer practical strategies for rural patients to manage supply and cold-chain needs.

Report adverse events to the TGA as required and work with ophthalmology colleagues for specialist review when uncommon events such as macular oedema or uveitis occur.

For patients seeking to compare options, discuss preservative-free trade-offs versus cost and check current PBS listings to identify the most affordable brand or generic available at the time of prescribing.